SCHEMBL2351027

SCHEMBL2351027

CC(C)(Oc1ccc(F)cc1-c1ccc(S(=O)(=O)c2cccc(F)c2)c(F)c1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.39
PTGDR2 Q9Y5Y4 7/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ABCC9 O60706 2/20 0.37
ABCC8 Q09428 2/20 0.37
KCNJ11 Q14654 2/20 0.37
KCNJ8 Q15842 2/20 0.37
HSD11B1 P28845 1/20 0.35
RORC P51449 1/20 0.35
PPARD Q03181 3/20 0.34
PPARA Q07869 3/20 0.34
ACLY P53396 1/20 0.34
PPARG P37231 2/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992334 0.87 KDM4E (0.39) PTGDR2KDM4EALDH1A1HSD17B10ABCC9
SCHEMBL1989562 0.83 PTGS2 (0.45) GRM5MEN1KMT2A
SCHEMBL1989829 0.83 ABCC9 (0.43) PTGDR2KDM4EALDH1A1HSD17B10ABCC9
SCHEMBL1993975 0.82 ABCB11 (0.48) GRM5PTGDR2PPARDPPARAPPARG
SCHEMBL2351025 0.80 PTGDR2 (0.40) GRM5PTGDR2PPARDPPARAPPARG
SCHEMBL1991394 0.79 ABCB11 (0.38) GRM5PTGDR2ABCC9ABCC8KCNJ11
SCHEMBL1989553 0.78 HTR6 (0.51) KDM4EALDH1A1ACLYMEN1KMT2A
SCHEMBL1988525 0.77 GRM5 (0.46) GRM5KDM4EALDH1A1HSD17B10ABCC9
SCHEMBL2356023 0.76 MMP2 (0.39) PTGDR2HSD11B1
SCHEMBL14432857 0.76 MMP2 (0.39) PTGDR2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed